RasGRPs Are Targets of the Anti-Cancer Agent Ingenol-3-Angelate

PLoS ONE- United States

doi 10.1371/journal.pone.0072331

Full Text

Abstract

Available in

Categories

Multidisciplinary

Date

August 21, 2013

Authors

Ana Lopez-Campistrous

Jessica S. Kelsey

Peter M. Blumberg

Publisher

Public Library of Science (PLoS)

Related search

Crystal Structure of the Calcium ATPase SERCA in Complex to a Novel Anti-Cancer Agent That Targets Multidrug-Resistant Leukemia

Biophysical Journal

English

The Prolyl 3-Hydroxylases P3H2 and P3H3 Are Novel Targets for Epigenetic Silencing in Breast Cancer

British Journal of Cancer

Cancer Research

English

Salinomycin: A Novel Anti-Cancer Agent With Known Anti-Coccidial Activities

Current Medicinal Chemistry

Organic Chemistry

Molecular Medicine

English

Biological Activities of Fusarochromanone: A Potent Anti-Cancer Agent

BMC Research Notes

Molecular Biology

English

Tetrac as an Anti-Angiogenic Agent in Cancer

Endocrine-Related Cancer

Cancer Research

English

Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies

Frontiers in Pharmacology

English

Largazole as a Novel and Selective Anti-Breast Cancer Agent

English

Antitumor Activity of 3-Ingenyl Angelate: Plasma Membrane and Mitochondrial Disruption and Necrotic Cell Death

Cancer Research

Cancer Research

English

Editorial: Matricellular Receptors as Potential Targets in Anti-Cancer Therapeutic Strategies

Frontiers in Pharmacology

English